Now Playing
Feature|Videos|August 5, 2026
Meet the Moderator of the Next-Generation Bioconjugation Panel
Key Takeaways
- Meet the moderator for this Peer Exchange.
- Understand the topic for this peer-to-peer discussion.
Meet the moderator for this Peer Exchange on Next-Gen Bioconjugation: Designing-in Analytical Precision and Efficiency.
Episodes in this series
Sponsored by Waters Corporation
Colette Quinn, Senior Director and Portfolio Owner at Waters Corporation, introduces herself and welcomes viewers to this Peer Exchange. Her expertise lies in antibody drug conjugates—both cystine and lysine conjugated species.
Related Content
